Press Releases

 Filter by Provider

Brain tumors, such as glioblastoma, are very hard to treat and even surgery isn’t sufficient to fully remove the tumor since tiny particles of cancerous cells remain and proliferate within a short time. However, ongoing work at Cedars-Sinai promises to transform brain cancer treatment by creating a digital twin of a patient’s tumor and then predicting how the cancer will grow and how it could respond to different therapies. In this way, treatment teams can better personalize treatments for individual patients.

Questions are mounting in Silicon Valley over whether the skyrocketing valuations of artificial intelligence firms are truly justified. A growing number of investors and analysts are warning that the sector may be inflating faster than its true potential, raising concerns about a potential financial bubble.

Q3 2025 was a busy quarter once again for us here at illumynt. In addition to naming a new CEO, we executed on a number of initiatives that are propelling our organization forward.

Electric vehicles used for e-commerce deliveries could dramatically reduce urban emissions as online shopping continues expanding globally, the United Nations Environment Program (UNEP) says.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Altamirano PLLC, a New York-based securities arbitration law firm, has announced an investigation into the brokerage firms that sold Inspired Healthcare Capital (IHC) investments.

Honoring First Responders with Premium Challenge Coins, Medals, and Other Promotional Products

New feature enables businesses to remotely transform any Android device into a dynamic digital sign, kiosk, or information hub.

IgnitionX enhances BioMedWire and ESGWireNews with measurable reach, intelligent targeting and deeper engagement among investors.

Croak Capital has established itself as a trusted resource for ultra-high-net-worth (UHNW) families in Toledo by focusing on a specialized approach to family office advisory.

SAN DIEGO, CA, TX / ACCESS Newswire / October 17, 2025 / Envela Corporation ("Envela" or the "Company") today announced that it will present at the 19th annual LD Micro Main Event on Monday, October 20th at 2:30 PM PT, at the Hotel del Coronado in San Diego, California. John DeLuca, Chief Financial Officer of Envela Corporation, will deliver the Company's presentation.

100 MWh Rondo Heat Battery, world's most efficient energy storage of any kind, now delivering 24-hour steam from off-grid solar power - proving a new path for factories to cut carbon and costs

Kolter Homes marks seven years of Artistry Palm Beach with an event highlighting the community's design, lifestyle, and final homesites.

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the study increased considerably to 76.2% (95% CI: 63.8, 86.0) by blinded independent review committee (BICR) per RECIST v1.1, from 54% at Week 25. The study also showed continued clinically meaningful improvements in key secondary endpoints related to patient outcomes such as pain and function. The safety profile was consistent with previously reported data. The results are being presented today in the Sarcoma mini-oral session at the European Society for Medical Oncology (ESMO) Congress 2025 (Presentation # 2690MO).

Initial results from one sub-study of the TROPION-PanTumor03 phase 2 trial showed that DATROWAY® (datopotamab deruxtecan) plus rilvegostomig showed promising tumor responses and disease control as first-line and second-line combination therapy in patients with locally advanced or metastatic urothelial cancer. These results were presented today as a mini oral session (3072MO) at the 2025 European Society for Medical Oncology (#ESMO25) Congress.

Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer, today announced at the ESMO Congress 2025 the first-ever clinical data showing that its investigational FOG-001 therapy has successfully drugged β-catenin:TCF – a key cancer-driving node in the Wnt/β-catenin pathway, until now considered “undruggable.”

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Jefferies Financial Group Inc. (“Jefferies” or the “Company”) (NYSE: JEF) investors concerning the Company’s possible violations of the federal securities laws.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RCI Hospitality Holdings, Inc. (“RCI” or the “Company”) (NASDAQ: RICK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc (“WPP” or the “Company”) (NYSE: WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Quanex Building Products Corporation (“Quanex” or the “Company”) (NYSE: NX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in KBR, Inc. of, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate (“Cytokinetics” or the “Company”) (NASDAQ: CYTK).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fly-E Group, Inc. (“Fly-E” or the “Company”) (NASDAQ: FLYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against VF Corporation (“VFC” or the “Company”) (NYSE: VFC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Lukas Weber, a 46-year-old office worker in Vancouver, Canada, is also a Bitcoin enthusiast. He began exploring cryptocurrencies in 2020, hoping to achieve financial freedom by buying and selling Bitcoin. However, the reality hasn't been as rosy as he imagined.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced it is generating approximately $10 million in annualized revenue through its portfolio of income-producing robotics and hospitality assets. The milestone underscores the company’s transition into a high-growth enterprise built on hotel acquisitions and its expanding Robotics-as-a-Service (RaaS) platform. CEO Jimmy Chan said the achievement validates NGTF’s integrated growth model and highlights the company’s focus on scaling its AI-driven hospitality automation strategy to deliver long-term shareholder value.

Gold Coast, Australia - 17 October, 2025 - Entrepreneur Simon Beard, co-founder of Culture Kings, has officially launched the Creator Army Bootcamp—a program designed to train and certify a new wave of AI-assisted Full-Stack Content Creators and create one million jobs for the next generation of digital talent.

India based Hindustan Zinc Limited, a Vedanta Group company and the world’s largest integrated zinc producer, announced its financial results on 17th October 2025 for the second quarter and half year ended 30th September 2025. The company reported its best-ever second quarter mined metal production of 258 Kt, alongside five-year lowest zinc cost of production excluding royalty at $994 per tonne. The company also recorded its highest-ever 2Q revenue from operations of US$ 979 million, up 10% QoQ and 4% YoY, and best-ever second-quarter EBITDA of US$ 512 million, up 16% QoQ and 7% YoY, maintaining industry-leading EBITDA margin of 52%. Resultantly, profit after tax stood at US$ 303 million, rising 19% QoQ and 14% YoY.

CAFÉ™, the brand synonymous with customizable hardware offerings that create flexibility in kitchen design, partnered with actress Kate Hudson to transform her kitchen into a space that reflects her unique taste and lifestyle.

Chico, California--(Newsfile Corp. - October 17, 2025) - AmeraMex International, Inc. (OTC Pink: AMMX), a leading provider of heavy equipment...

Despite progress on sweeping reforms to its insurance regulations, Argentina remains a volatile environment for insurers due to high inflation, currency depreciation and investment uncertainty, which pressures solvency ratios and complicates capital management, according to a new AM Best commentary.

XRP has always drawn bold forecasts. Some voices ask, could Ripple really reach $100? Such a leap would dwarf most altcoin rallies. In this context, Remittix deserves mention because, unlike XRP’s speculative plays, Remittix is built on a real payments infrastructure.

The "European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

SAN JOSE, CA, MA / ACCESS Newswire / October 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, reported its financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024").

FORT MILL, SC / ACCESS Newswire / October 17, 2025 / Sharonview Federal Credit Union, a longstanding financial institution in the North and South Carolina communities for 70 years, has partnered with Elan Financial Services to give back to the community through a charitable donation to Harvest Hope Food Bank in honor of International Credit Union Day on October 16.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tronox Holdings Plc (“Tronox” or the “Company”) (NYSE: TROX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Quantum Corporation (“Quantum” or the “Company”)(NASDAQ: QMCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Constitution Insurance Company (Constitution) (Cambridge, NY). The outlook of these Credit Ratings (ratings) is stable.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Dogecoin just landed its own ETF and that changes everything. The DOGE price today is riding ETF-driven waves, and DOGE price prediction chatter is heating up. As Dogecoin news floods the feeds, investors are hunting for the next 100x cryptos with real potential.

New York, New York--(Newsfile Corp. - October 17, 2025) - New analysis by OysterLink of the latest Bureau of Labor...

The "Middle East Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc.  (“Jasper” or the “Company”) (NASDAQ: JSPR) and certain officers.   The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Jasper securities between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. (“C3” or the “Company”) (NYSE: AI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PubMatic, Inc. (“PubMatic” or the “Company”) (NASDAQ: PUBM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) and certain officers.   The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under 25-cv-02496, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fluor securities between February 18, 2025 and July 31, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.